Profile of the Running ES Score & Positions of GeneSet Members on the Rank Ordered List
| Dataset | double_gel_and_single_gel_rma_expression_values_collapsed_to_symbols.class.cls #double_gel_8d_versus_single_gel_8d.class.cls #double_gel_8d_versus_single_gel_8d_repos |
| Phenotype | class.cls#double_gel_8d_versus_single_gel_8d_repos |
| Upregulated in class | single_gel_8d |
| GeneSet | REGULATION_OF_CELL_PROLIFERATION |
| Enrichment Score (ES) | -0.4246845 |
| Normalized Enrichment Score (NES) | -1.7176172 |
| Nominal p-value | 0.0 |
| FDR q-value | 0.07434222 |
| FWER p-Value | 1.0 |
| PROBE | GENE SYMBOL | GENE_TITLE | RANK IN GENE LIST | RANK METRIC SCORE | RUNNING ES | CORE ENRICHMENT | |
|---|---|---|---|---|---|---|---|
| 1 | PLG | PLG Entrez, Source | plasminogen | 44 | 0.773 | 0.0242 | No |
| 2 | IGF1 | IGF1 Entrez, Source | insulin-like growth factor 1 (somatomedin C) | 236 | 0.445 | 0.0255 | No |
| 3 | CXCL1 | CXCL1 Entrez, Source | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 309 | 0.392 | 0.0339 | No |
| 4 | RARRES1 | RARRES1 Entrez, Source | retinoic acid receptor responder (tazarotene induced) 1 | 325 | 0.381 | 0.0463 | No |
| 5 | MDM4 | MDM4 Entrez, Source | Mdm4, transformed 3T3 cell double minute 4, p53 binding protein (mouse) | 605 | 0.265 | 0.0346 | No |
| 6 | CTF1 | CTF1 Entrez, Source | cardiotrophin 1 | 648 | 0.252 | 0.0403 | No |
| 7 | IL1B | IL1B Entrez, Source | interleukin 1, beta | 695 | 0.240 | 0.0454 | No |
| 8 | BTG2 | BTG2 Entrez, Source | BTG family, member 2 | 724 | 0.234 | 0.0516 | No |
| 9 | TGFA | TGFA Entrez, Source | transforming growth factor, alpha | 740 | 0.230 | 0.0586 | No |
| 10 | FGFBP1 | FGFBP1 Entrez, Source | fibroblast growth factor binding protein 1 | 975 | 0.197 | 0.0478 | No |
| 11 | CSF3 | CSF3 Entrez, Source | colony stimulating factor 3 (granulocyte) | 1134 | 0.178 | 0.0421 | No |
| 12 | PTPRC | PTPRC Entrez, Source | protein tyrosine phosphatase, receptor type, C | 1238 | 0.168 | 0.0403 | No |
| 13 | CHRNA10 | CHRNA10 Entrez, Source | cholinergic receptor, nicotinic, alpha 10 | 1265 | 0.167 | 0.0442 | No |
| 14 | EGR4 | EGR4 Entrez, Source | early growth response 4 | 1292 | 0.165 | 0.0481 | No |
| 15 | FGF18 | FGF18 Entrez, Source | fibroblast growth factor 18 | 1301 | 0.164 | 0.0533 | No |
| 16 | CDH13 | CDH13 Entrez, Source | cadherin 13, H-cadherin (heart) | 1338 | 0.162 | 0.0564 | No |
| 17 | TSHR | TSHR Entrez, Source | thyroid stimulating hormone receptor | 1351 | 0.160 | 0.0612 | No |
| 18 | VEGFB | VEGFB Entrez, Source | vascular endothelial growth factor B | 1471 | 0.151 | 0.0575 | No |
| 19 | PBEF1 | PBEF1 Entrez, Source | pre-B-cell colony enhancing factor 1 | 1558 | 0.145 | 0.0561 | No |
| 20 | TNFRSF8 | TNFRSF8 Entrez, Source | tumor necrosis factor receptor superfamily, member 8 | 1639 | 0.141 | 0.0550 | No |
| 21 | FLT1 | FLT1 Entrez, Source | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 1835 | 0.129 | 0.0448 | No |
| 22 | SPDYA | SPDYA Entrez, Source | speedy homolog A (Drosophila) | 1994 | 0.122 | 0.0371 | No |
| 23 | CD86 | CD86 Entrez, Source | CD86 molecule | 2005 | 0.121 | 0.0406 | No |
| 24 | CDK6 | CDK6 Entrez, Source | cyclin-dependent kinase 6 | 2067 | 0.119 | 0.0402 | No |
| 25 | CCKBR | CCKBR Entrez, Source | cholecystokinin B receptor | 2185 | 0.115 | 0.0354 | No |
| 26 | LIF | LIF Entrez, Source | leukemia inhibitory factor (cholinergic differentiation factor) | 2346 | 0.109 | 0.0271 | No |
| 27 | IL2 | IL2 Entrez, Source | interleukin 2 | 2505 | 0.102 | 0.0187 | No |
| 28 | MCTS1 | MCTS1 Entrez, Source | malignant T cell amplified sequence 1 | 2515 | 0.102 | 0.0217 | No |
| 29 | IGFBP6 | IGFBP6 Entrez, Source | insulin-like growth factor binding protein 6 | 2548 | 0.101 | 0.0228 | No |
| 30 | RUNX3 | RUNX3 Entrez, Source | runt-related transcription factor 3 | 2707 | 0.095 | 0.0142 | No |
| 31 | ACVRL1 | ACVRL1 Entrez, Source | activin A receptor type II-like 1 | 2768 | 0.093 | 0.0129 | No |
| 32 | FGF10 | FGF10 Entrez, Source | fibroblast growth factor 10 | 2836 | 0.090 | 0.0110 | No |
| 33 | GNRH1 | GNRH1 Entrez, Source | gonadotropin-releasing hormone 1 (luteinizing-releasing hormone) | 2893 | 0.088 | 0.0099 | No |
| 34 | SFTPD | SFTPD Entrez, Source | surfactant, pulmonary-associated protein D | 3017 | 0.084 | 0.0035 | No |
| 35 | OPRM1 | OPRM1 Entrez, Source | opioid receptor, mu 1 | 3053 | 0.083 | 0.0039 | No |
| 36 | TBRG4 | TBRG4 Entrez, Source | transforming growth factor beta regulator 4 | 3101 | 0.081 | 0.0032 | No |
| 37 | POU3F2 | POU3F2 Entrez, Source | POU domain, class 3, transcription factor 2 | 3182 | 0.079 | -0.0001 | No |
| 38 | CGREF1 | CGREF1 Entrez, Source | cell growth regulator with EF-hand domain 1 | 3238 | 0.077 | -0.0015 | No |
| 39 | IL6 | IL6 Entrez, Source | interleukin 6 (interferon, beta 2) | 3320 | 0.076 | -0.0050 | No |
| 40 | RHOG | RHOG Entrez, Source | ras homolog gene family, member G (rho G) | 3472 | 0.072 | -0.0139 | No |
| 41 | AGGF1 | AGGF1 Entrez, Source | angiogenic factor with G patch and FHA domains 1 | 3586 | 0.069 | -0.0201 | No |
| 42 | FABP6 | FABP6 Entrez, Source | fatty acid binding protein 6, ileal (gastrotropin) | 3608 | 0.068 | -0.0193 | No |
| 43 | EREG | EREG Entrez, Source | epiregulin | 3625 | 0.068 | -0.0181 | No |
| 44 | CSF1 | CSF1 Entrez, Source | colony stimulating factor 1 (macrophage) | 3716 | 0.066 | -0.0226 | No |
| 45 | IL1A | IL1A Entrez, Source | interleukin 1, alpha | 3784 | 0.064 | -0.0254 | No |
| 46 | MYC | MYC Entrez, Source | v-myc myelocytomatosis viral oncogene homolog (avian) | 3805 | 0.064 | -0.0246 | No |
| 47 | CDK2 | CDK2 Entrez, Source | cyclin-dependent kinase 2 | 3808 | 0.064 | -0.0225 | No |
| 48 | AIF1 | AIF1 Entrez, Source | allograft inflammatory factor 1 | 3839 | 0.063 | -0.0225 | No |
| 49 | SSTR1 | SSTR1 Entrez, Source | somatostatin receptor 1 | 3940 | 0.061 | -0.0280 | No |
| 50 | SCIN | SCIN Entrez, Source | scinderin | 3942 | 0.061 | -0.0259 | No |
| 51 | TSPAN31 | TSPAN31 Entrez, Source | tetraspanin 31 | 3955 | 0.061 | -0.0246 | No |
| 52 | IGF1R | IGF1R Entrez, Source | insulin-like growth factor 1 receptor | 4105 | 0.057 | -0.0339 | No |
| 53 | TBX3 | TBX3 Entrez, Source | T-box 3 (ulnar mammary syndrome) | 4143 | 0.056 | -0.0347 | No |
| 54 | INHA | INHA Entrez, Source | inhibin, alpha | 4183 | 0.055 | -0.0357 | No |
| 55 | PCAF | PCAF Entrez, Source | p300/CBP-associated factor | 4209 | 0.055 | -0.0357 | No |
| 56 | BTG1 | BTG1 Entrez, Source | B-cell translocation gene 1, anti-proliferative | 4354 | 0.052 | -0.0448 | No |
| 57 | SSTR5 | SSTR5 Entrez, Source | somatostatin receptor 5 | 4509 | 0.048 | -0.0548 | No |
| 58 | TNFSF12 | TNFSF12 Entrez, Source | tumor necrosis factor (ligand) superfamily, member 12 | 4529 | 0.048 | -0.0546 | No |
| 59 | IL4 | IL4 Entrez, Source | interleukin 4 | 4550 | 0.047 | -0.0544 | No |
| 60 | SSR1 | SSR1 Entrez, Source | signal sequence receptor, alpha (translocon-associated protein alpha) | 4574 | 0.047 | -0.0545 | No |
| 61 | NF2 | NF2 Entrez, Source | neurofibromin 2 (bilateral acoustic neuroma) | 4606 | 0.046 | -0.0552 | No |
| 62 | COL18A1 | COL18A1 Entrez, Source | collagen, type XVIII, alpha 1 | 4715 | 0.044 | -0.0619 | No |
| 63 | CHRNA7 | CHRNA7 Entrez, Source | cholinergic receptor, nicotinic, alpha 7 | 4725 | 0.043 | -0.0610 | No |
| 64 | CGRRF1 | CGRRF1 Entrez, Source | cell growth regulator with ring finger domain 1 | 4893 | 0.040 | -0.0723 | No |
| 65 | B4GALT7 | B4GALT7 Entrez, Source | xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I) | 4905 | 0.040 | -0.0717 | No |
| 66 | VIPR1 | VIPR1 Entrez, Source | vasoactive intestinal peptide receptor 1 | 4908 | 0.040 | -0.0705 | No |
| 67 | IL3 | IL3 Entrez, Source | interleukin 3 (colony-stimulating factor, multiple) | 5075 | 0.036 | -0.0818 | No |
| 68 | TBX5 | TBX5 Entrez, Source | T-box 5 | 5116 | 0.036 | -0.0836 | No |
| 69 | CXCL10 | CXCL10 Entrez, Source | chemokine (C-X-C motif) ligand 10 | 5128 | 0.035 | -0.0832 | No |
| 70 | POU1F1 | POU1F1 Entrez, Source | POU domain, class 1, transcription factor 1 (Pit1, growth hormone factor 1) | 5246 | 0.033 | -0.0909 | No |
| 71 | CD164 | CD164 Entrez, Source | CD164 molecule, sialomucin | 5266 | 0.032 | -0.0912 | No |
| 72 | PTHLH | PTHLH Entrez, Source | parathyroid hormone-like hormone | 5428 | 0.029 | -0.1024 | No |
| 73 | TSC1 | TSC1 Entrez, Source | tuberous sclerosis 1 | 5506 | 0.028 | -0.1073 | No |
| 74 | IL8RB | IL8RB Entrez, Source | interleukin 8 receptor, beta | 5537 | 0.027 | -0.1086 | No |
| 75 | GLMN | GLMN Entrez, Source | glomulin, FKBP associated protein | 5660 | 0.024 | -0.1170 | No |
| 76 | PTN | PTN Entrez, Source | pleiotrophin (heparin binding growth factor 8, neurite growth-promoting factor 1) | 5682 | 0.024 | -0.1178 | No |
| 77 | HTR1A | HTR1A Entrez, Source | 5-hydroxytryptamine (serotonin) receptor 1A | 5728 | 0.023 | -0.1204 | No |
| 78 | BTG4 | BTG4 Entrez, Source | B-cell translocation gene 4 | 5769 | 0.022 | -0.1226 | No |
| 79 | FIGF | FIGF Entrez, Source | c-fos induced growth factor (vascular endothelial growth factor D) | 5779 | 0.022 | -0.1225 | No |
| 80 | LYN | LYN Entrez, Source | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 5855 | 0.021 | -0.1275 | No |
| 81 | FGF7 | FGF7 Entrez, Source | fibroblast growth factor 7 (keratinocyte growth factor) | 5913 | 0.020 | -0.1311 | No |
| 82 | CDC2L5 | CDC2L5 Entrez, Source | cell division cycle 2-like 5 (cholinesterase-related cell division controller) | 5925 | 0.020 | -0.1312 | No |
| 83 | IL12B | IL12B Entrez, Source | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 5931 | 0.020 | -0.1309 | No |
| 84 | CHRM1 | CHRM1 Entrez, Source | cholinergic receptor, muscarinic 1 | 5978 | 0.019 | -0.1337 | No |
| 85 | JAG2 | JAG2 Entrez, Source | jagged 2 | 6015 | 0.018 | -0.1358 | No |
| 86 | HCLS1 | HCLS1 Entrez, Source | hematopoietic cell-specific Lyn substrate 1 | 6043 | 0.017 | -0.1373 | No |
| 87 | ELA2 | ELA2 Entrez, Source | elastase 2, neutrophil | 6385 | 0.010 | -0.1629 | No |
| 88 | NDUFS4 | NDUFS4 Entrez, Source | NADH dehydrogenase (ubiquinone) Fe-S protein 4, 18kDa (NADH-coenzyme Q reductase) | 6477 | 0.008 | -0.1695 | No |
| 89 | UMOD | UMOD Entrez, Source | uromodulin (uromucoid, Tamm-Horsfall glycoprotein) | 6490 | 0.008 | -0.1702 | No |
| 90 | SSTR2 | SSTR2 Entrez, Source | somatostatin receptor 2 | 6505 | 0.008 | -0.1710 | No |
| 91 | SPEG | SPEG Entrez, Source | SPEG complex locus | 6531 | 0.007 | -0.1726 | No |
| 92 | SCG2 | SCG2 Entrez, Source | secretogranin II (chromogranin C) | 6564 | 0.007 | -0.1748 | No |
| 93 | SSTR4 | SSTR4 Entrez, Source | somatostatin receptor 4 | 6572 | 0.007 | -0.1751 | No |
| 94 | EDG5 | EDG5 Entrez, Source | endothelial differentiation, sphingolipid G-protein-coupled receptor, 5 | 6662 | 0.005 | -0.1817 | No |
| 95 | NOX4 | NOX4 Entrez, Source | NADPH oxidase 4 | 6694 | 0.004 | -0.1839 | No |
| 96 | GLP2R | GLP2R Entrez, Source | glucagon-like peptide 2 receptor | 6732 | 0.004 | -0.1866 | No |
| 97 | GLI1 | GLI1 Entrez, Source | glioma-associated oncogene homolog 1 (zinc finger protein) | 6734 | 0.004 | -0.1866 | No |
| 98 | IL11 | IL11 Entrez, Source | interleukin 11 | 6783 | 0.003 | -0.1901 | No |
| 99 | NAP1L1 | NAP1L1 Entrez, Source | nucleosome assembly protein 1-like 1 | 6915 | -0.000 | -0.2001 | No |
| 100 | KLF4 | KLF4 Entrez, Source | Kruppel-like factor 4 (gut) | 7004 | -0.002 | -0.2067 | No |
| 101 | EDN1 | EDN1 Entrez, Source | endothelin 1 | 7069 | -0.004 | -0.2115 | No |
| 102 | SERTAD1 | SERTAD1 Entrez, Source | SERTA domain containing 1 | 7125 | -0.005 | -0.2155 | No |
| 103 | FTH1 | FTH1 Entrez, Source | ferritin, heavy polypeptide 1 | 7147 | -0.005 | -0.2169 | No |
| 104 | LST1 | LST1 Entrez, Source | leukocyte specific transcript 1 | 7191 | -0.006 | -0.2200 | No |
| 105 | MFN2 | MFN2 Entrez, Source | mitofusin 2 | 7196 | -0.006 | -0.2200 | No |
| 106 | DNAJA2 | DNAJA2 Entrez, Source | DnaJ (Hsp40) homolog, subfamily A, member 2 | 7402 | -0.010 | -0.2353 | No |
| 107 | VIP | VIP Entrez, Source | vasoactive intestinal peptide | 7425 | -0.011 | -0.2366 | No |
| 108 | FGF4 | FGF4 Entrez, Source | fibroblast growth factor 4 (heparin secretory transforming protein 1, Kaposi sarcoma oncogene) | 7557 | -0.014 | -0.2461 | No |
| 109 | CDKN2B | CDKN2B Entrez, Source | cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) | 7589 | -0.014 | -0.2479 | No |
| 110 | NME2 | NME2 Entrez, Source | non-metastatic cells 2, protein (NM23B) expressed in | 7595 | -0.014 | -0.2478 | No |
| 111 | IL7 | IL7 Entrez, Source | interleukin 7 | 7643 | -0.015 | -0.2508 | No |
| 112 | GTPBP4 | GTPBP4 Entrez, Source | GTP binding protein 4 | 7656 | -0.016 | -0.2512 | No |
| 113 | DHPS | DHPS Entrez, Source | deoxyhypusine synthase | 7692 | -0.016 | -0.2533 | No |
| 114 | SST | SST Entrez, Source | somatostatin | 7737 | -0.017 | -0.2560 | No |
| 115 | TNFSF13 | TNFSF13 Entrez, Source | tumor necrosis factor (ligand) superfamily, member 13 | 7907 | -0.021 | -0.2681 | No |
| 116 | NPM1 | NPM1 Entrez, Source | nucleophosmin (nucleolar phosphoprotein B23, numatrin) | 8204 | -0.028 | -0.2897 | No |
| 117 | MATK | MATK Entrez, Source | megakaryocyte-associated tyrosine kinase | 8223 | -0.028 | -0.2900 | No |
| 118 | CDKN2C | CDKN2C Entrez, Source | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) | 8322 | -0.030 | -0.2964 | No |
| 119 | NME1 | NME1 Entrez, Source | non-metastatic cells 1, protein (NM23A) expressed in | 8399 | -0.032 | -0.3010 | No |
| 120 | ADRA2A | ADRA2A Entrez, Source | adrenergic, alpha-2A-, receptor | 8458 | -0.033 | -0.3043 | No |
| 121 | MAGED1 | MAGED1 Entrez, Source | melanoma antigen family D, 1 | 8492 | -0.034 | -0.3056 | No |
| 122 | KLF10 | KLF10 Entrez, Source | Kruppel-like factor 10 | 8626 | -0.037 | -0.3144 | No |
| 123 | GHRL | GHRL Entrez, Source | ghrelin/obestatin preprohormone | 8739 | -0.040 | -0.3215 | No |
| 124 | TNFSF4 | TNFSF4 Entrez, Source | tumor necrosis factor (ligand) superfamily, member 4 (tax-transcriptionally activated glycoprotein 1, 34kDa) | 9004 | -0.046 | -0.3400 | No |
| 125 | CUL5 | CUL5 Entrez, Source | cullin 5 | 9220 | -0.052 | -0.3545 | No |
| 126 | CDKN3 | CDKN3 Entrez, Source | cyclin-dependent kinase inhibitor 3 (CDK2-associated dual specificity phosphatase) | 9252 | -0.053 | -0.3550 | No |
| 127 | PTEN | PTEN Entrez, Source | phosphatase and tensin homolog (mutated in multiple advanced cancers 1) | 9345 | -0.056 | -0.3600 | No |
| 128 | HOXC10 | HOXC10 Entrez, Source | homeobox C10 | 9351 | -0.056 | -0.3584 | No |
| 129 | CLEC11A | CLEC11A Entrez, Source | C-type lectin domain family 11, member A | 9373 | -0.057 | -0.3580 | No |
| 130 | GNL3 | GNL3 Entrez, Source | guanine nucleotide binding protein-like 3 (nucleolar) | 9498 | -0.060 | -0.3653 | No |
| 131 | PGF | PGF Entrez, Source | placental growth factor, vascular endothelial growth factor-related protein | 9515 | -0.060 | -0.3643 | No |
| 132 | ING1 | ING1 Entrez, Source | inhibitor of growth family, member 1 | 9723 | -0.066 | -0.3778 | No |
| 133 | CDKN2D | CDKN2D Entrez, Source | cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) | 9788 | -0.068 | -0.3802 | No |
| 134 | CTBP1 | CTBP1 Entrez, Source | C-terminal binding protein 1 | 9803 | -0.068 | -0.3789 | No |
| 135 | CNOT8 | CNOT8 Entrez, Source | CCR4-NOT transcription complex, subunit 8 | 9823 | -0.069 | -0.3779 | No |
| 136 | BRCA2 | BRCA2 Entrez, Source | breast cancer 2, early onset | 10026 | -0.075 | -0.3906 | No |
| 137 | TOB1 | TOB1 Entrez, Source | transducer of ERBB2, 1 | 10157 | -0.080 | -0.3976 | No |
| 138 | EGFR | EGFR Entrez, Source | epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian) | 10171 | -0.080 | -0.3957 | No |
| 139 | ADRA1A | ADRA1A Entrez, Source | adrenergic, alpha-1A-, receptor | 10237 | -0.083 | -0.3977 | No |
| 140 | APC | APC Entrez, Source | adenomatosis polyposis coli | 10296 | -0.085 | -0.3991 | No |
| 141 | FRK | FRK Entrez, Source | fyn-related kinase | 10336 | -0.086 | -0.3991 | No |
| 142 | WARS | WARS Entrez, Source | tryptophanyl-tRNA synthetase | 10462 | -0.090 | -0.4054 | No |
| 143 | CAPN1 | CAPN1 Entrez, Source | calpain 1, (mu/I) large subunit | 10465 | -0.091 | -0.4023 | No |
| 144 | CAPNS1 | CAPNS1 Entrez, Source | calpain, small subunit 1 | 10660 | -0.097 | -0.4136 | No |
| 145 | ADAMTS1 | ADAMTS1 Entrez, Source | ADAM metallopeptidase with thrombospondin type 1 motif, 1 | 10664 | -0.097 | -0.4103 | No |
| 146 | MXI1 | MXI1 Entrez, Source | MAX interactor 1 | 10722 | -0.099 | -0.4112 | No |
| 147 | ATPIF1 | ATPIF1 Entrez, Source | ATPase inhibitory factor 1 | 10815 | -0.103 | -0.4145 | No |
| 148 | EMP3 | EMP3 Entrez, Source | epithelial membrane protein 3 | 10906 | -0.107 | -0.4175 | No |
| 149 | CD81 | CD81 Entrez, Source | CD81 molecule | 10933 | -0.108 | -0.4156 | No |
| 150 | SCYE1 | SCYE1 Entrez, Source | small inducible cytokine subfamily E, member 1 (endothelial monocyte-activating) | 10959 | -0.110 | -0.4136 | No |
| 151 | ARHGEF2 | ARHGEF2 Entrez, Source | rho/rac guanine nucleotide exchange factor (GEF) 2 | 11105 | -0.117 | -0.4205 | Yes |
| 152 | EIF2AK2 | EIF2AK2 Entrez, Source | eukaryotic translation initiation factor 2-alpha kinase 2 | 11121 | -0.118 | -0.4175 | Yes |
| 153 | FOSL1 | FOSL1 Entrez, Source | FOS-like antigen 1 | 11180 | -0.120 | -0.4176 | Yes |
| 154 | CDCA7 | CDCA7 Entrez, Source | cell division cycle associated 7 | 11253 | -0.124 | -0.4186 | Yes |
| 155 | STAMBP | STAMBP Entrez, Source | STAM binding protein | 11308 | -0.127 | -0.4182 | Yes |
| 156 | NF1 | NF1 Entrez, Source | neurofibromin 1 (neurofibromatosis, von Recklinghausen disease, Watson disease) | 11321 | -0.127 | -0.4146 | Yes |
| 157 | CDC25B | CDC25B Entrez, Source | cell division cycle 25B | 11352 | -0.129 | -0.4123 | Yes |
| 158 | NUP62 | NUP62 Entrez, Source | nucleoporin 62kDa | 11369 | -0.129 | -0.4089 | Yes |
| 159 | CD47 | CD47 Entrez, Source | CD47 molecule | 11473 | -0.136 | -0.4119 | Yes |
| 160 | CDK10 | CDK10 Entrez, Source | cyclin-dependent kinase (CDC2-like) 10 | 11493 | -0.137 | -0.4085 | Yes |
| 161 | TGFBR2 | TGFBR2 Entrez, Source | transforming growth factor, beta receptor II (70/80kDa) | 11501 | -0.137 | -0.4041 | Yes |
| 162 | GAS8 | GAS8 Entrez, Source | growth arrest-specific 8 | 11506 | -0.138 | -0.3995 | Yes |
| 163 | BRCA1 | BRCA1 Entrez, Source | breast cancer 1, early onset | 11523 | -0.139 | -0.3958 | Yes |
| 164 | TM4SF4 | TM4SF4 Entrez, Source | transmembrane 4 L six family member 4 | 11537 | -0.140 | -0.3918 | Yes |
| 165 | FLT4 | FLT4 Entrez, Source | fms-related tyrosine kinase 4 | 11547 | -0.140 | -0.3875 | Yes |
| 166 | HGS | HGS Entrez, Source | hepatocyte growth factor-regulated tyrosine kinase substrate | 11569 | -0.141 | -0.3841 | Yes |
| 167 | GPX1 | GPX1 Entrez, Source | glutathione peroxidase 1 | 11620 | -0.145 | -0.3827 | Yes |
| 168 | BMPR2 | BMPR2 Entrez, Source | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 11635 | -0.146 | -0.3786 | Yes |
| 169 | TOB2 | TOB2 Entrez, Source | transducer of ERBB2, 2 | 11652 | -0.147 | -0.3746 | Yes |
| 170 | BTG3 | BTG3 Entrez, Source | BTG family, member 3 | 11661 | -0.148 | -0.3699 | Yes |
| 171 | PAWR | PAWR Entrez, Source | PRKC, apoptosis, WT1, regulator | 11680 | -0.149 | -0.3660 | Yes |
| 172 | TBRG1 | TBRG1 Entrez, Source | transforming growth factor beta regulator 1 | 11701 | -0.150 | -0.3622 | Yes |
| 173 | CD28 | CD28 Entrez, Source | CD28 molecule | 11745 | -0.152 | -0.3601 | Yes |
| 174 | TCIRG1 | TCIRG1 Entrez, Source | T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3 | 11841 | -0.159 | -0.3616 | Yes |
| 175 | IL12RB2 | IL12RB2 Entrez, Source | interleukin 12 receptor, beta 2 | 11883 | -0.163 | -0.3589 | Yes |
| 176 | ABI1 | ABI1 Entrez, Source | abl-interactor 1 | 12095 | -0.181 | -0.3686 | Yes |
| 177 | VHL | VHL Entrez, Source | von Hippel-Lindau tumor suppressor | 12112 | -0.183 | -0.3633 | Yes |
| 178 | CDKN1A | CDKN1A Entrez, Source | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 12163 | -0.188 | -0.3604 | Yes |
| 179 | IL15 | IL15 Entrez, Source | interleukin 15 | 12233 | -0.197 | -0.3586 | Yes |
| 180 | ERBB2 | ERBB2 Entrez, Source | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 12237 | -0.197 | -0.3518 | Yes |
| 181 | ING4 | ING4 Entrez, Source | inhibitor of growth family, member 4 | 12380 | -0.212 | -0.3551 | Yes |
| 182 | FABP3 | FABP3 Entrez, Source | fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor) | 12473 | -0.224 | -0.3541 | Yes |
| 183 | IL18 | IL18 Entrez, Source | interleukin 18 (interferon-gamma-inducing factor) | 12497 | -0.228 | -0.3477 | Yes |
| 184 | NRP1 | NRP1 Entrez, Source | neuropilin 1 | 12499 | -0.229 | -0.3397 | Yes |
| 185 | TGFB1I1 | TGFB1I1 Entrez, Source | transforming growth factor beta 1 induced transcript 1 | 12535 | -0.233 | -0.3340 | Yes |
| 186 | TGFBR1 | TGFBR1 Entrez, Source | transforming growth factor, beta receptor I (activin A receptor type II-like kinase, 53kDa) | 12538 | -0.234 | -0.3258 | Yes |
| 187 | PRKRA | PRKRA Entrez, Source | protein kinase, interferon-inducible double stranded RNA dependent activator | 12555 | -0.237 | -0.3186 | Yes |
| 188 | S100A11 | S100A11 Entrez, Source | S100 calcium binding protein A11 | 12634 | -0.251 | -0.3156 | Yes |
| 189 | TIMELESS | TIMELESS Entrez, Source | timeless homolog (Drosophila) | 12644 | -0.253 | -0.3073 | Yes |
| 190 | PDGFA | PDGFA Entrez, Source | platelet-derived growth factor alpha polypeptide | 12698 | -0.263 | -0.3020 | Yes |
| 191 | SPHK1 | SPHK1 Entrez, Source | sphingosine kinase 1 | 12700 | -0.264 | -0.2926 | Yes |
| 192 | CDKN1C | CDKN1C Entrez, Source | cyclin-dependent kinase inhibitor 1C (p57, Kip2) | 12725 | -0.270 | -0.2848 | Yes |
| 193 | NOTCH2 | NOTCH2 Entrez, Source | Notch homolog 2 (Drosophila) | 12734 | -0.272 | -0.2757 | Yes |
| 194 | BTC | BTC Entrez, Source | betacellulin | 12772 | -0.279 | -0.2686 | Yes |
| 195 | PTK2B | PTK2B Entrez, Source | PTK2B protein tyrosine kinase 2 beta | 12778 | -0.280 | -0.2590 | Yes |
| 196 | ETS1 | ETS1 Entrez, Source | v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) | 12786 | -0.282 | -0.2495 | Yes |
| 197 | CDK4 | CDK4 Entrez, Source | cyclin-dependent kinase 4 | 12794 | -0.284 | -0.2399 | Yes |
| 198 | CHEK1 | CHEK1 Entrez, Source | CHK1 checkpoint homolog (S. pombe) | 12821 | -0.294 | -0.2314 | Yes |
| 199 | TGFB2 | TGFB2 Entrez, Source | transforming growth factor, beta 2 | 12832 | -0.296 | -0.2217 | Yes |
| 200 | LAMC1 | LAMC1 Entrez, Source | laminin, gamma 1 (formerly LAMB2) | 12835 | -0.298 | -0.2112 | Yes |
| 201 | CD276 | CD276 Entrez, Source | CD276 molecule | 12865 | -0.308 | -0.2024 | Yes |
| 202 | ADRA1D | ADRA1D Entrez, Source | adrenergic, alpha-1D-, receptor | 13056 | -0.402 | -0.2026 | Yes |
| 203 | CDKN2A | CDKN2A Entrez, Source | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 13099 | -0.425 | -0.1907 | Yes |
| 204 | IGFBP7 | IGFBP7 Entrez, Source | insulin-like growth factor binding protein 7 | 13198 | -0.561 | -0.1781 | Yes |
| 205 | GPNMB | GPNMB Entrez, Source | glycoprotein (transmembrane) nmb | 13207 | -0.576 | -0.1583 | Yes |
| 206 | CTBP2 | CTBP2 Entrez, Source | C-terminal binding protein 2 | 13212 | -0.580 | -0.1379 | Yes |
| 207 | TIMP1 | TIMP1 Entrez, Source | TIMP metallopeptidase inhibitor 1 | 13213 | -0.582 | -0.1172 | Yes |
| 208 | NDN | NDN Entrez, Source | necdin homolog (mouse) | 13215 | -0.586 | -0.0964 | Yes |
| 209 | CXCL5 | CXCL5 Entrez, Source | chemokine (C-X-C motif) ligand 5 | 13257 | -0.714 | -0.0741 | Yes |
| 210 | FABP7 | FABP7 Entrez, Source | fatty acid binding protein 7, brain | 13272 | -0.767 | -0.0478 | Yes |
| 211 | CD24 | CD24 Entrez, Source | CD24 molecule | 13337 | -1.491 | 0.0004 | Yes |
